127 related articles for article (PubMed ID: 34153292)
1. Bim transfer between Bcl-2-like protein and Hsp70 underlines Bcl-2/Hsp70 crosstalk to regulate apoptosis.
Zhang H; Guo Z; Guo Y; Wang Z; Tang Y; Song T; Zhang Z
Biochem Pharmacol; 2021 Aug; 190():114660. PubMed ID: 34153292
[TBL] [Abstract][Full Text] [Related]
2. The chaperone Hsp70 is a BH3 receptor activated by the pro-apoptotic Bim to stabilize anti-apoptotic clients.
Guo Z; Song T; Wang Z; Lin D; Cao K; Liu P; Feng Y; Zhang X; Wang P; Yin F; Dai J; Zhou S; Zhang Z
J Biol Chem; 2020 Sep; 295(37):12900-12909. PubMed ID: 32651234
[TBL] [Abstract][Full Text] [Related]
3. Ectopic BH3-only protein Bim acts as a cochaperone to positively regulate Hsp70 in yeast.
Pan H; Song T; Wang Z; Guo Y; Zhang H; Ji T; Cao K; Zhang Z
J Biochem; 2021 Dec; 170(4):539-545. PubMed ID: 34185080
[TBL] [Abstract][Full Text] [Related]
4. Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.
Bajpai R; Matulis SM; Wei C; Nooka AK; Von Hollen HE; Lonial S; Boise LH; Shanmugam M
Oncogene; 2016 Jul; 35(30):3955-64. PubMed ID: 26640142
[TBL] [Abstract][Full Text] [Related]
5. A novel Hsp70 inhibitor specifically targeting the cancer-related Hsp70-Bim protein-protein interaction.
Wang Z; Song T; Guo Z; Uwituze LB; Guo Y; Zhang H; Wang H; Zhang X; Pan H; Ji T; Yin F; Zhou S; Dai J; Zhang Z
Eur J Med Chem; 2021 Aug; 220():113452. PubMed ID: 33906046
[TBL] [Abstract][Full Text] [Related]
6. High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.
Bate-Eya LT; den Hartog IJ; van der Ploeg I; Schild L; Koster J; Santo EE; Westerhout EM; Versteeg R; Caron HN; Molenaar JJ; Dolman ME
Oncotarget; 2016 May; 7(19):27946-58. PubMed ID: 27056887
[TBL] [Abstract][Full Text] [Related]
7. Bcr-Abl drives the formation of Hsp70/Bim PPI to stabilize oncogenic clients and prevent cells from undergoing apoptosis.
Zhang H; Song T; Wang Z; Laura Bonnette U; Guo Y; Wang H; Gao Q; Zhang Z
Biochem Pharmacol; 2022 Apr; 198():114964. PubMed ID: 35182521
[TBL] [Abstract][Full Text] [Related]
8. Exploiting the "Hot-Spots" of Hsp70
Wang Z; Zhang H; Li X; Song Y; Wang Y; Hu Z; Gao Q; Jiang M; Yin F; Yuan L; Liu J; Song T; Lu S; Xu G; Zhang Z
J Med Chem; 2023 Dec; 66(23):16377-16387. PubMed ID: 38011535
[TBL] [Abstract][Full Text] [Related]
9. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
[TBL] [Abstract][Full Text] [Related]
10. The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.
Pétigny-Lechartier C; Duboc C; Jebahi A; Louis MH; Abeilard E; Denoyelle C; Gauduchon P; Poulain L; Villedieu M
Mol Cancer Ther; 2017 Jan; 16(1):102-115. PubMed ID: 27980105
[TBL] [Abstract][Full Text] [Related]
11. BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma.
Ishida CT; Bianchetti E; Shu C; Halatsch ME; Westhoff MA; Karpel-Massler G; Siegelin MD
Oncotarget; 2017 May; 8(18):29558-29573. PubMed ID: 28418907
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
de Jong MRW; Langendonk M; Reitsma B; Nijland M; van den Berg A; Ammatuna E; Visser L; van Meerten T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801186
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic and mitochondrial ROS production resulted in apoptosis induction in breast cancer cells treated with Crocin: The role of FOXO3a, PTEN and AKT signaling.
Nasimian A; Farzaneh P; Tamanoi F; Bathaie SZ
Biochem Pharmacol; 2020 Jul; 177():113999. PubMed ID: 32353423
[TBL] [Abstract][Full Text] [Related]
15. Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivo.
Zhou L; Zhang Y; Sampath D; Leverson J; Dai Y; Kmieciak M; Nguyen M; Orlowski RZ; Grant S
Br J Cancer; 2018 Feb; 118(3):388-397. PubMed ID: 29241222
[TBL] [Abstract][Full Text] [Related]
16. BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.
Heinicke U; Haydn T; Kehr S; Vogler M; Fulda S
Oncogene; 2018 Sep; 37(39):5325-5339. PubMed ID: 29858601
[TBL] [Abstract][Full Text] [Related]
17. Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70.
Stankiewicz AR; Livingstone AM; Mohseni N; Mosser DD
Cell Death Differ; 2009 Apr; 16(4):638-47. PubMed ID: 19148187
[TBL] [Abstract][Full Text] [Related]
18. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
[TBL] [Abstract][Full Text] [Related]
19. Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis.
Gomez-Bougie P; Halliez M; Moreau P; Pellat-Deceunynck C; Amiot M
Cancer Lett; 2016 Dec; 383(2):204-211. PubMed ID: 27697610
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance.
Song T; Zhang H; Zhao Q; Hu Z; Wang Z; Song Y; Zhang Z
Breast Cancer Res; 2024 Feb; 26(1):33. PubMed ID: 38409088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
